STOCK MARKET BSE NSE

Coming soon! Bharat Biotech's CoroFlu vaccine to beat coronavirus pandemic

Bharat Biotech on Friday announced that a unique intranasal vaccine, CoroFlu, is under development for Covid-19 and human clinical trials could begin by the fall of 2020.

Published: 04th April 2020 08:47 AM  |   Last Updated: 04th April 2020 08:47 AM   |  A+A-

Health workers on duty at LNJP Hospital in New Delhi on Friday

Health workers on duty at LNJP Hospital in New Delhi on Friday. (Photo| Shekhar Yadav, EPS)

By Express News Service

NEW DELHI: Bharat Biotech on Friday announced that a unique intranasal vaccine, CoroFlu, is under development for COVID-19 and human clinical trials could begin by the fall of 2020. An international collaboration of virologists at the University of Wisconsin-Madison and the vaccine company FluGen, along with Bharat Biotech, has begun the development and testing of the vaccine.

Sharing details about CoroFlu collaboration, Dr Raches Ella, Head of Business Development, Bharat Biotech said, "Bharat Biotech will manufacture the vaccine, conduct clinical trials and prepare to produce almost 300 million doses of vaccine for global distribution. Under the collaboration agreement, FluGen will transfer its existing manufacturing processes to Bharat Biotech to enable the company to scale up production and produce the vaccine for clinical trials."

Refinement of the CoroFlu vaccine concept and testing in lab animal models at the University of Wisconsin-Madison is expected to take three to six months. Bharat Biotech will then begin production scale-up for safety and efficacy testing in humans.

CoroFlu is based on the influenza vaccine and will provide immunity against the H2N2 strain of seasonal influenza. "Of late, we have more seasonal flu problems which is also getting into pandemic. We are attempting to solve both the problems together with a new approach," he said.

Stay up to date on all the latest Nation news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp